Novocure (NVCR) Stock Rating Reaffirmed by JPMorgan Chase & Co.

‘s stock had its “overweight” rating reiterated by analysts at JPMorgan Chase & Co. in a research report issued on Monday, Analyst Ratings.Net reports.